Seattle Genetics | القيمة السوقية



Market Capitalization تغيير تاريخ
AbbVie USD 370.64B 56.62B 2025-03
Agios Pharmaceuticals USD 1.7B 178M 2025-03
Amgen USD 167.51B 27.54B 2025-03
Astellas Pharma JPY 2.62T 139.38B 2025-03
Bayer EUR 21.7B 2.69B 2025-03
Biogen USD 20.03B 2.25B 2025-03
BioMarin Pharmaceutical USD 13.56B 1.02B 2025-03
Bristol-Myers Squibb USD 124.1B 9.39B 2025-03
Celldex Therapeutics USD 1.2B 473M 2025-03
Daiichi Sankyo JPY 6.7T 1.77T 2025-03
Eisai JPY 1.21T 53.66B 2025-03
Eli Lilly USD 741.66B 8.79B 2025-03
Exelixis USD 10.33B 823M 2025-03
Genmab DKK 88.7B 10.08B 2025-03
Gilead Sciences USD 139.68B 24.59B 2025-03
GlaxoSmithKline GBP 60.35B 4.54B 2025-03
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 11.72B 1.59B 2025-03
Insmed USD 13.88B 1.5B 2025-03
MacroGenics USD 204M 3M 2024-12
Merck USD 225.87B 25.78B 2025-03
Moderna USD 10.96B 5.04B 2025-03
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 143.72B 6.63B 2025-03
Sanofi EUR 125.84B 7.44B 2025-03
Sarepta Therapeutics USD 6.19B 5.59B 2025-03
Takeda JPY 7.02T 410.88B 2025-03
Teva Pharmaceutical Industries ILS 64.02B 27.9B 2025-03
Xencor USD 750M 858M 2025-03



Seattle Genetics القيمة السوقية - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.